|
ADSS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.03300000000328E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.166880E-04 |
| Normal-vs-Stage2 |
7.72450000000591E-05 |
| Normal-vs-Stage3 |
3.234800E-01 |
| Normal-vs-Stage4 |
4.426000E-02 |
| Stage1-vs-Stage2 |
7.335600E-01 |
| Stage1-vs-Stage3 |
1.147400E-01 |
| Stage1-vs-Stage4 |
5.355200E-01 |
| Stage2-vs-Stage3 |
9.061700E-02 |
| Stage2-vs-Stage4 |
3.993200E-01 |
| Stage3-vs-Stage4 |
5.755200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.65559999999654E-05 |
| Normal-vs-AfricanAmerican |
1.955990E-04 |
| Normal-vs-Asian |
1.939380E-01 |
| Caucasian-vs-AfricanAmerican |
7.814800E-01 |
| Caucasian-vs-Asian |
6.030000E-01 |
| AfricanAmerican-vs-Asian |
5.106400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.65289999998208E-06 |
| Normal-vs-Female |
1.571590E-01 |
| Male-vs-Female |
1.359000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.288100E-02 |
| Normal-vs-Extreme_Weight |
1.98929999994935E-06 |
| Normal-vs-Obese |
1.976410E-03 |
| Normal-vs-Extreme_Obese |
3.245900E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.774980E-01 |
| Normal_Weight-vs-Obese |
8.536400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.107360E-01 |
| Extreme_Weight-vs-Obese |
1.569010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.693800E-01 |
| Obese-vs-Extreme_Obese |
2.576400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.689800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.043100E-03 |
| Normal-vs-Age(61-80Yrs) |
5.95789999999763E-05 |
| Normal-vs-Age(81-100Yrs) |
2.89789999996515E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.020800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.748600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.754000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.960200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.243500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.194450E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.00600000000484E-05 |
| Normal-VS-Type2 PRCC |
5.955300E-04 |
| Normal-VS-KIRP CIMP |
2.750200E-01 |
| Normal-VS-Unclassified PRCC |
1.235900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.408600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.846600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.391000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.368800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.404200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.326580E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.42790000000759E-05 |
| Normal-vs-N1 |
5.953200E-01 |
| Normal-vs-N2 |
1.751980E-01 |
| N0-vs-N1 |
4.310400E-02 |
| N0-vs-N2 |
5.700200E-01 |
| N1-vs-N2 |
5.917800E-01 |
|
|
